Kansas State University

Fully two years into the COVID-19 pandemic, biopharmaceutical companies and academic/non-profit research organizations continue to partner on efforts to prevent and combat infections by the SARS-CoV-2

Tonix Looks To Prevent, Treat, Provide Precision Medicine In COVID-19 In the past month, Tonix Pharmaceuticals Holding Corp. has unveiled three separate partnerships to advance its efforts towards a

It's still a long-term development proposition, but the opportunity to deliver genes locally to the heart as therapy is large enough, and the need to innovate so great, that device companies are chang